COMPLIANCE POLICY GUIDE (CPG)
CPG Sec. 460.700 Controlled Release Dosage Form Drugs - Rate of Release of Active Ingredients
Revocation/Deletion
This CPG was Revoked. See 21 CFR 310.502(a)(14)
Issued: 1/1/73
Revised: 7/1/80, 9/4/87
Revoked: 08/19/2005 (Obsolete - Superseded by 21 CFR 310.502(a)(14) )
Updated: 12/06/05
Page created: tc 08/22/2005
Submit Comments
Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All comments should be identified with the title of the guidance.